aid: arrivent-biopharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrivent-biopharma.png
name: ArriVent Biopharma
description: 'ArriVent BioPharma (NASDAQ: AVBP) is a clinical-stage biopharmaceutical company dedicated
  to the identification, development, and commercialization of differentiated medicines for the treatment
  of cancer. Its lead candidate is firmonertinib, an EGFR inhibitor being studied across non-small cell
  lung cancer indications, and its pipeline includes next-generation antibody drug conjugates such as
  ARR-002. The company operates by identifying novel oncology programs, in-licensing drug candidates
  through partnerships, and designing regulatory-compliant clinical development strategies. It was surfaced
  as a portfolio company of HongShan and added to the API Evangelist network; as a traditional pharmaceutical
  developer it publishes no public API, developer portal, or technical integration surface.'
url: https://raw.githubusercontent.com/api-evangelist/arrivent-biopharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- hongshan
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Biopharmaceutical
- Oncology
- Pharmaceuticals
- Clinical Trials
- Drug Development
apis: []
common:
- type: DomainSecurity
  url: security/arrivent-biopharma-domain-security.yml
- type: Website
  url: https://www.arrivent.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence